Changes of verruciform xanthoma in an HIV-1+ patient with diffuse psoriasiform skin disease. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Changes of verruciform xanthoma in an HIV-1+ patient with diffuse psoriasiform skin disease.

Am J Dermatopathol. 1995 Apr;17(2):185-8. Unique Identifier : AIDSLINE MED/96166791
Smith KJ; Skelton HG; Angritt P; Walter Reed Army Institute of Research, Washington, DC, USA.

Abstract: Verruciform xanthoma occurs most commonly in the oral mucosa; however, rare cutaneous lesions have been described. Although the pathogenesis of this entity is not known, dysregulation of epithelial proliferation and degenerative changes in the epithelium may explain the occurrence of this lesion in association with inflammatory dermatoses, epithelial hamartomas, and epithelial dysplasia. We report an HIV-1+ patient with diffuse psoriasiform skin lesions that showed histologic changes of verruciform xanthoma.
Keywords: Case Report Cell Division Eosinophils/PATHOLOGY Epidermis/PATHOLOGY Epithelium/PATHOLOGY Exocytosis Human HIV Seropositivity/*PATHOLOGY Keratinocytes/PATHOLOGY Keratosis/PATHOLOGY Leukocytes, Mononuclear/PATHOLOGY Lichenoid Eruptions/PATHOLOGY Male Middle Age Neutrophils/PATHOLOGY Papilloma/PATHOLOGY Psoriasis/*PATHOLOGY Skin Neoplasms/PATHOLOGY Xanthomatosis/*PATHOLOGY JOURNAL ARTICLEKWDcasereportcelldivisioneosinophils/pathologyepidermis/pathologyepithelium/pathologyexocytosishumanhivseropositivity/KWDpathologykeratinocytes/pathologykeratosis/pathologyleukocytes,mononuclear/pathologylichenoideruptions/pathologymalemiddleageneutrophils/pathologypapilloma/pathologypsoriasis/KWDpathologyskinneoplasms/pathologyxanthomatosis/KWDpathologyjournalarticle
960730
M9670480

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .